Parsifal Capital Management, LP Bio Rad Laboratories, Inc. Transaction History
Parsifal Capital Management, LP
- $1.06 Billion
- Q2 2024
A detailed history of Parsifal Capital Management, LP transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Parsifal Capital Management, LP holds 128,882 shares of BIO stock, worth $44.3 Million. This represents 3.34% of its overall portfolio holdings.
Number of Shares
128,882
Previous 178,013
27.6%
Holding current value
$44.3 Million
Previous $61.6 Million
42.83%
% of portfolio
3.34%
Previous 5.16%
Shares
3 transactions
Others Institutions Holding BIO
# of Institutions
460Shares Held
19.6MCall Options Held
23.2KPut Options Held
37.4K-
Vanguard Group Inc Valley Forge, PA2.37MShares$816 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$533 Million0.01% of portfolio
-
Veritas Asset Management LLP1.13MShares$388 Million2.63% of portfolio
-
State Street Corp Boston, MA860KShares$296 Million0.01% of portfolio
-
Van Eck Associates Corp659KShares$227 Million0.26% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.47B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...